Literature DB >> 7596989

Carrier-mediated transport can obey fractal kinetics.

P Macheras1.   

Abstract

A model based on the fractal methodology is proposed for the kinetic study of carrier-mediated transport under heterogeneous conditions, i.e., when the drug-carrier interaction occurs at an interface with an effective dimensionality smaller than the embedding dimension of d = 2. A model equation is derived for the flux, based on a similar approach for an analogous equation for enzyme kinetics. It is shown that the total flux-solute concentration plots are curvilinear when the fractal dimension is smaller than unity while they become biexponential, with ascending and descending limbs, when the fractal dimension D is in the range 1 < D < 2. Nonlinear Lineweaver-Burk plots are obtained when this fractal kinetics approach is used. Good fittings are obtained when the fractal model is applied to literature data previously analysed with a combined transport mechanism, revealing experimental systems that display a D value in the range 1 < D < 2. It is suggested that transport studies should be carried out at a wider working solute concentration range and various agitation and incubation conditions in order to derive definite conclusions for the transport pathways.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7596989     DOI: 10.1023/a:1016201929304

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  12 in total

Review 1.  Cell culture techniques for the study of drug transport.

Authors:  G Wilson
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1990 Apr-Jun       Impact factor: 2.441

2.  Fractal reaction kinetics.

Authors:  R Kopelman
Journal:  Science       Date:  1988-09-23       Impact factor: 47.728

3.  Fractal model of ion-channel kinetics.

Authors:  L S Liebovitch; J Fischbarg; J P Koniarek; I Todorova; M Wang
Journal:  Biochim Biophys Acta       Date:  1987-01-26

4.  An experimental method of identifying and quantifying the active transfer electrogenic component from the diffusive component during sugar absorption measured in vivo.

Authors:  E S Debnam; R J Levin
Journal:  J Physiol       Date:  1975-03       Impact factor: 5.182

5.  Intestinal absorption by carrier-mediated transports: two-dimensional laminar flow model.

Authors:  H Yuasa; Y Miyamoto; T Iga; M Hanano
Journal:  J Theor Biol       Date:  1986-03-07       Impact factor: 2.691

6.  Derivation of the equations that describe the effects of unstirred water layers on the kinetic parameters of active transport processes in the intestine.

Authors:  A B Thomson; J M Dietschy
Journal:  J Theor Biol       Date:  1977-01-21       Impact factor: 2.691

7.  Determination of transport rates for arginine and acetaminophen in rabbit intestinal tissues in vitro.

Authors:  P W Swaan; G J Marks; F M Ryan; P L Smith
Journal:  Pharm Res       Date:  1994-02       Impact factor: 4.200

8.  Experimental diabetes and intestinal barriers to absorption.

Authors:  A B Thomson
Journal:  Am J Physiol       Date:  1983-02

9.  Biotin uptake and transport across bovine brain microvessel endothelial cell monolayers.

Authors:  F Shi; C Bailey; A W Malick; K L Audus
Journal:  Pharm Res       Date:  1993-02       Impact factor: 4.200

10.  Structural requirements for the intestinal mucosal-cell peptide transporter: the need for N-terminal alpha-amino group.

Authors:  P F Bai; P Subramanian; H I Mosberg; G L Amidon
Journal:  Pharm Res       Date:  1991-05       Impact factor: 4.200

View more
  9 in total

1.  Michaelis-Menten kinetics under spatially constrained conditions: application to mibefradil pharmacokinetics.

Authors:  Kosmas Kosmidis; Vangelis Karalis; Panos Argyrakis; Panos Macheras
Journal:  Biophys J       Date:  2004-09       Impact factor: 4.033

2.  Fractional kinetics in drug absorption and disposition processes.

Authors:  Aristides Dokoumetzidis; Panos Macheras
Journal:  J Pharmacokinet Pharmacodyn       Date:  2009-04-02       Impact factor: 2.745

3.  A new approach to the compartmental analysis in pharmacokinetics: fractional time evolution of diclofenac.

Authors:  Jovan K Popović; Milica T Atanacković; Ana S Pilipović; Milan R Rapaić; Stevan Pilipović; Teodor M Atanacković
Journal:  J Pharmacokinet Pharmacodyn       Date:  2010-01-14       Impact factor: 2.745

Review 4.  Fractal geometry, fractal kinetics and chaos en route to biopharmaceutical sciences.

Authors:  P Macheras; P Argyrakis; C Polymilis
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1996 Apr-Jun       Impact factor: 2.441

5.  Application of fractal kinetics for carrier-mediated transport of drugs across intestinal epithelial membrane.

Authors:  T Ogihara; I Tamai; A Tsuji
Journal:  Pharm Res       Date:  1998-04       Impact factor: 4.200

6.  A fractal approach to heterogeneous drug distribution: calcium pharmacokinetics.

Authors:  P Macheras
Journal:  Pharm Res       Date:  1996-05       Impact factor: 4.200

7.  Interpreting airborne pandemics spreading using fractal kinetics' principles.

Authors:  Panos Macheras; Athanasios A Tsekouras; Pavlos Chryssafidis
Journal:  F1000Res       Date:  2021-07-20

8.  Fractal michaelis-menten kinetics under steady state conditions: Application to mibefradil.

Authors:  Rebeccah E Marsh; Jack A Tuszyński
Journal:  Pharm Res       Date:  2006-10-25       Impact factor: 4.580

9.  Comparison of the gamma-Pareto convolution with conventional methods of characterising metformin pharmacokinetics in dogs.

Authors:  Carl A Wesolowski; Surajith N Wanasundara; Paul S Babyn; Jane Alcorn
Journal:  J Pharmacokinet Pharmacodyn       Date:  2019-12-21       Impact factor: 2.745

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.